Skip to main navigation Skip to search Skip to main content

The pandemic brain: Neuroinflammation in non-infected individuals during the COVID-19 pandemic

  • Ludovica Brusaferri
  • , Zeynab Alshelh
  • , Daniel Martins
  • , Minhae Kim
  • , Akila Weerasekera
  • , Hope Housman
  • , Erin J. Morrissey
  • , Paulina C. Knight
  • , Kelly A. Castro-Blanco
  • , Daniel S. Albrecht
  • , Chieh En Tseng
  • , Nicole R. Zürcher
  • , Eva Maria Ratai
  • , Oluwaseun Akeju
  • , Meena M. Makary
  • , Ciprian Catana
  • , Nathaniel D. Mercaldo
  • , Nouchine Hadjikhani
  • , Mattia Veronese
  • , Federico Turkheimer
  • Bruce R. Rosen, Jacob M. Hooker, Marco L. Loggia
  • Athinoula A. Martinos Center for Biomedical Imaging
  • Harvard University
  • King's College London
  • NIHR Maudsley Biomedical Research Centre
  • Cairo University
  • University of Gothenburg
  • University of Padua

Research output: Contribution to journalArticlepeer-review

32 Citations (Scopus)
6 Downloads (Pure)

Abstract

While COVID-19 research has seen an explosion in the literature, the impact of pandemic-related societal and lifestyle disruptions on brain health among the uninfected remains underexplored. However, a global increase in the prevalence of fatigue, brain fog, depression and other “sickness behavior”-like symptoms implicates a possible dysregulation in neuroimmune mechanisms even among those never infected by the virus. We compared fifty-seven ‘Pre-Pandemic’ and fifteen ‘Pandemic’ datasets from individuals originally enrolled as control subjects for various completed, or ongoing, research studies available in our records, with a confirmed negative test for SARS-CoV-2 antibodies. We used a combination of multimodal molecular brain imaging (simultaneous positron emission tomography / magnetic resonance spectroscopy), behavioral measurements, imaging transcriptomics and serum testing to uncover links between pandemic-related stressors and neuroinflammation. Healthy individuals examined after the enforcement of 2020 lockdown/stay-at-home measures demonstrated elevated brain levels of two independent neuroinflammatory markers (the 18 kDa translocator protein, TSPO, and myoinositol) compared to pre-lockdown subjects. The serum levels of two inflammatory markers (interleukin-16 and monocyte chemoattractant protein-1) were also elevated, although these effects did not reach statistical significance after correcting for multiple comparisons. Subjects endorsing higher symptom burden showed higher TSPO signal in the hippocampus (mood alteration, mental fatigue), intraparietal sulcus and precuneus (physical fatigue), compared to those reporting little/no symptoms. Post-lockdown TSPO signal changes were spatially aligned with the constitutive expression of several genes involved in immune/neuroimmune functions. This work implicates neuroimmune activation as a possible mechanism underlying the non-virally-mediated symptoms experienced by many during the COVID-19 pandemic. Future studies will be needed to corroborate and further interpret these preliminary findings.

Original languageEnglish
Pages (from-to)89-97
Number of pages9
JournalBrain, Behavior, and Immunity
Volume102
DOIs
Publication statusPublished - 13 Feb 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2022 Elsevier Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Mental health
  • MRS
  • Neuroimaging
  • Pandemic
  • PET
  • Stress

Fingerprint

Dive into the research topics of 'The pandemic brain: Neuroinflammation in non-infected individuals during the COVID-19 pandemic'. Together they form a unique fingerprint.

Cite this